Zymeworks Inc. SEC filings ZYME

Zymeworks Inc. has 337 filings in SEC EDGAR's recent list, going back to Jul 15, 2022. Its latest annual report, Form ARS, was filed on Oct 26, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 6, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 23, 2026 (material agreement, regulation fd disclosure). The company's fiscal year ends on December 31.

Form Description Filed Period
DEFA14A Additional proxy material Oct 26, 2026 —
DEF 14A Proxy statement Oct 26, 2026 Dec 15, 2026
PRE 14A Preliminary proxy statement Oct 16, 2026 Dec 15, 2026
DEFA14A Additional proxy material Nov 10, 2025 —
DEF 14A Proxy statement Nov 10, 2025 Dec 30, 2025
DEFA14A Additional proxy material Oct 29, 2024 —
DEF 14A Proxy statement Oct 29, 2024 Dec 10, 2024
DEFA14A Additional proxy material Oct 26, 2023 —
DEF 14A Proxy statement Oct 26, 2023 Dec 7, 2023
DEFA14A Additional proxy material Dec 8, 2022 —
DEF 14A Proxy statement Nov 25, 2022 Dec 16, 2022

Showing 11 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
ZYME (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Middletown, DE
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1937653
Former names
Zymeworks Delaware Inc. (until Oct 13, 2022)

Other Pharmaceutical Preparations companies

All 570 Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.